Table 1 Sequences for quantitative PCR with reverse transcription primers or siRNA targets.

From: Hepatocyte TM4SF5-mediated cytosolic NCOA3 stabilization and macropinocytosis support albumin uptake and bioenergetics for hepatocellular carcinoma progression

Gene names

Sequences

Forward primer (5′ → 3′)

Reverse primer (5′ → 3′)

ITGA4

TGAATGTGTCCTTGTTTAATGCTG

TTGTACCACGCCAGAGTTATC

ITGA5

ATACTCTGTGGCTGTTGGTG

CTGTTCCCCTGAGAAGTTGTAG

DMD (Dystrophin)

GAACTGGCTGCTGAATGTTTATG

CGCTTCGATCTCTGGCTTATT

SLC1A5

GAAGTGCGTGGAGGAGAATAA

CAGCCAGGATCAAGGAGATATG

GAPDH

CCAGCCGAGCCACATCGCTC

ATGAGCCCCAGCCTTCTCCAT

Gene names

siRNA target sequence

Forward (5′ → 3′)

Reverse (5′ → 3′)

ITGA2

GAAACGCCCUUGAUACUAAAAAUTT

AAAUUUUUAGUAUCAAGGGCGUUUCUG

NCOA3

AAACCAGCAGAAUAUCAUGAUUUCT

AGAAAUCAUGAUAUUCUGCUGGUUUGG

ITGA4

GGUACUGCAUUCUGAAUCAGAAUCT

AGAUUCUGAUUCAGAAUGCAGUACCUG

ITGA5

CUACAAGCUUGGAUUCUUCAAACGC

GCGUUUGAAGAAUCCAAGCU UGUAGAG

DMD (Dystrophin)

CUUAGUAUCAGUCAUGACAGAUGAA

UUCAUCUGUCAUGACUGAUACUAAGGA

SLC1A5

GAUCUUGCGAGAAAUAUCUUCCCTT

AAGGGAAGAUAUUUCUCGCAAGAUCC

siTM4SF5#4

CCA UCU CAG CUU GCA AGU C

GAC UUG CAA GCU GAG AUG G

siTM4SF5#7

CCUCCU GCU GGU ACC UAA U

AUU AGG UAC CAG CAG GAG G

siNS

GenePharma negative control no. A06001